loader image

Eradocate

EraDOCate logo
One Product. A Smarter Alternative to Quat-Based Complexity

Move Beyond Quat-Based Complexity

Keep broad pathogen readiness. Reduce product complexity.

EraDOCate gives facilities one quat-free disinfection platform built around broad EPA-labeled pathogen coverage, short contact times, closed-loop dilution, one training standard, residue-conscious workflows, and measurable implementation. Where it replaces multiple ready-to-use products, facilities can also evaluate opportunities for less inventory, less storage, less packaging, and less material movement.

Why facilities are reassessing multi-product quat-based workflows

1
Fast routine workflowMany label-listed organisms use a 1-minute wet contact time with EraDOCator-60, helping teams keep the protocol practical during real operating turnover.
2
Fewer products to manageEvaluate where one platform can reduce disinfectant SKUs, duplicate inventory, product switching, and protocol variation while keeping claim-specific directions clear.
3
High-consequence pathogen readinessC. difficile, C. auris, and Poliovirus Type 1 use a clearly defined 4-minute protocol. Buyers can verify the complete preparation directions on the current label.
4
One training standardOCEAN gives teams one shared language built around Oxidate, Clean Slate, the EraDOCate System, the labeled contact time, and a residue-conscious finish across departments and shifts.
5
Measurable operating valueConcentration checks, training records, supervisor review, purchasing data, product-count changes, and ATP where appropriate can help facilities measure implementation and operating impact.
Talk through your current disinfectant program. For product, protocol, value-analysis, facility review, and OCEAN Standard discussions.
1 (866) ERADOCATE
Cleaner chemistry does not mean hazard-free chemistry.

EraDOCate relies on closed-loop dilution, label-based preparation, PPE, training, and verification to manage exposure appropriately. Concentrate handling, application method, ventilation where applicable, spill response, first aid, storage, surface compatibility and other safety requirements remain governed by the current EPA label, SDS, equipment instructions and facility policy.

The OCEAN Standard

The acronym stays the same across every EraDOCate page. The operating details change by facility, but the five pillars do not.

O — Oxidate

Use the EraDOCate chemistry platform according to the current EPA-accepted label and applicable facility procedures.

C — Clean Slate

Establish a clean, measurable starting point before disinfection and verify the process where appropriate.

E — EraDOCate System

Connect controlled dilution, application, PPE, training, verification, documentation, and coaching into one operating standard.

A — Allow the Labeled Contact Time

Use the contact time required for the exact organism and labeled use. Many label-listed organisms use a 1-minute contact time, while specific organisms require longer contact times.

N — No Residue

Support a residue-conscious finish where the current label and use directions apply, while keeping rinse and finish requirements tied to the exact labeled use.

The Opportunity Is Bigger Than Replacing One Chemical

The real opportunity is to simplify the whole disinfection footprint: pathogen coverage, contact time, product count, purchasing, storage, internal distribution, training, packaging, waste handling, workflow, and verification.

1. Keep contact time practical

Choose a protocol staff can execute during real room, classroom, guest-room, kitchen, or resident-space turnover.

2. Reduce product and protocol complexity

Give teams fewer product decisions, fewer disinfectant SKUs to manage, clearer instructions, and one more consistent operating standard.

3. Keep high-risk organisms inside the same platform

Keep C. difficile, C. auris, and Poliovirus Type 1 inside the same operating platform with defined 4-minute label-based protocols rather than adding another disinfectant decision.

4. Measure the whole program

Use concentration checks, training records, supervisor review, purchasing data, product count, storage, packaging, waste-handling data, and facility metrics to see what changes when the new standard is implemented.

One Product. A Better Daily Operating Standard

EraDOCate is designed to make disinfection easier to teach, execute, standardize, purchase, store, distribute, and verify.

Move from product complexity to clearer execution.

The OCEAN Standard connects one product platform to the same five pillars used across EraDOCate: Oxidate, Clean Slate, EraDOCate System, Allow the Labeled Contact Time, and No Residue.

Training

One shared framework helps simplify onboarding across departments, shifts, locations, and languages while reducing product-specific training variation.

Residue-conscious workflow

Give facilities a clearer way to think about repeated use on high-touch surfaces and use-specific rinse requirements.

Contact time

Build the labeled wet contact time into the workflow instead of leaving it as a line on a product label.

Frontline execution

Make the process workable for EVS, custodial, housekeeping, food-service, nursing, and animal-care teams.

Standardization

Reduce unnecessary product variation, duplicate inventory, and product switching while keeping organism-specific protocols clear.

Verification

Use concentration checks, training records, supervisor review, purchasing and inventory data, and ATP where appropriate to support process improvement.

The goal is simple: one disinfection platform that is easier for staff to follow and easier for leadership, Procurement, Operations, and Sustainability to manage.

Why Disinfection Exposure Is Part of the Evaluation

Newer research is giving healthcare, education, hospitality, senior living, food service, veterinary, medical aesthetics and wellness, and public-facility leaders more reasons to look closely at repeated disinfectant exposure and application methods.

Healthcare leaders are evaluating efficacy, exposure, residue, and operational consistency together.

Research on QACs is expanding across inhalation, occupational exposure, surface residue, and environmental pathways. For many buyers, that makes a quat-free alternative worth evaluating alongside efficacy, workflow, and cost.

What this means for a facility

You do not have to wait for every scientific question to be settled before comparing options. A practical next step is to review what the current chemistry requires every day and whether a quat-free platform can meet the facility’s efficacy and workflow requirements with a simpler, more verifiable operating model.

1

Pathogen control

Any alternative still has to meet the facility's organism-specific efficacy requirements.

2

Worker exposure

EVS, housekeeping, food-service, custodial, nursing, and care teams work around disinfectants repeatedly.

3

Occupant environment

Patients, residents, children, guests, students, and animals return to treated spaces every day.

4

Application method

Spraying, wiping, dilution, ventilation, and frequency all shape how a disinfectant is used in the real world.

5

Stewardship

Facilities increasingly want strong infection prevention with less unnecessary product, packaging, storage, and chemical complexity.

EraDOCate gives facilities a quat-free option that can be evaluated on efficacy, workflow, product consolidation, training, residue-conscious use, packaging and storage considerations, and implementation support.

Research links are provided for due diligence and do not establish that one disinfectant chemistry is hazard-free. Always review the current product label, SDS, PPE requirements, application method, ventilation considerations, surface compatibility, and facility policy.

Environmental Stewardship Starts Before the Disinfectant Reaches the Surface

Environmental stewardship is also a materials-management decision. Facilities can look at what enters the building, how much product is shipped and stored, how many containers move through closets and departments, and what ultimately enters recycling, waste, drains, and wastewater.

Measure the whole disinfection footprint.

A modern procurement decision can consider infection prevention, product count, freight, storage, internal material movement, packaging, waste handling, staff workflow, wastewater pathways, and long-term stewardship together.

Packaging & source reduction

Where one concentrated platform replaces multiple ready-to-use products, facilities can evaluate opportunities to reduce the number of bottles, canisters, cartons, and other packages entering the organization.

Storage & inventory

Fewer disinfectant SKUs and less ready-to-use inventory may reduce closet, EVS, housekeeping, central-supply, and storeroom space devoted to chemical products.

Freight & material movement

Point-of-use dilution gives facilities a reason to evaluate how much finished-use solution, packaging, case volume, and pallet space is being transported, received, stocked, and moved internally.

Waste & recycling burden

Reducing packaging at the source may reduce the containers that staff must collect, sort, recycle, discard, or otherwise manage after use.

Wastewater & downstream pathways

Facilities can still evaluate drains, rinse requirements, wastewater pathways, laundry, and repeated-use chemistry as part of responsible procurement and facility stewardship.

One Health & long-term stewardship

Healthcare, food systems, veterinary care, public facilities, and community environments increasingly connect human health, worker experience, animal health, water, materials use, and environmental stewardship.

EraDOCate gives buyers a different chemistry and operating model to evaluate across pathogen control, product consolidation, packaging, storage, freight, waste handling, wastewater, and broader stewardship.

Environmental references are provided to support facility due diligence and purchasing discussions. They do not establish that EraDOCate has no environmental impact; use and disposal should follow the current label, SDS, facility procedures, and applicable requirements.

Why the C. auris Question Matters

Quats remain common in routine disinfection, but C. auris is a clear example of why facilities should look beyond familiarity and compare organism-specific claims.

Quats are familiar

Many facilities have used quat-based products for years, which makes them easy to keep renewing without re-evaluating the whole program.

C. auris changes the conversation

CDC states that products solely dependent on QACs are not effective against C. auris and recommends an EPA-registered product effective against this organism.

EraDOCator-60 offers a defined alternative

EraDOCator-60 has a 4-minute label-listed C. auris protocol, giving facilities a clear option to evaluate.

What Changes When One Platform Replaces Product Complexity?

EraDOCate is not positioned as another disinfectant added to the shelf. The opportunity is to determine whether one product platform can replace unnecessary disinfectant complexity across purchasing, storage, training, routine use, and outbreak readiness.

Healthcare Review Alignment

EraDOCate supports healthcare evaluation through EPA registration documentation, label-based claims, standardized workflows, training resources, and verification processes.

Infection Prevention

Reviews organism claims, contact times, environmental requirements, and workflow alignment.

Environmental Services

Evaluates dilution, training, competency, room turnover, and daily execution.

Safety & Quality

Supports documentation, policies, monitoring, and implementation review.

Procurement & Administration

Evaluates documentation, product count, purchasing, storage, packaging, standardization opportunities, total operating fit, and value-analysis considerations.

Typical questions in an established quat program

  • How many products, containers, and contact times are staff expected to manage?
  • Which product is used when C. auris or C. difficile is a concern?
  • How often do rinse, residue, compatibility, or dilution questions come up?
  • How is correct use verified across shifts and departments?
  • Is the current system easy to purchase, store, teach, audit, and scale?

EraDOCate OCEAN Standard

  • One product platform with broad coverage and clear claim-specific protocols.
  • 1-minute workflow for many label-listed organisms.
  • 4-minute protocol for C. difficile, C. auris, and Poliovirus Type 1.
  • Closed-loop dilution and concentration verification.
  • OCEAN training, multilingual support, and facility implementation review.
The value proposition is not just the chemistry. It is one product platform combining label-based efficacy, training, standardization, dilution control, verification, and the opportunity to reduce inventory, storage, packaging, and product-handling complexity.

The Future State: One Product. Simpler. Clearer. Measurable.

A preferred disinfectant should make the organization easier to run, not add another bottle, canister, SKU, protocol, or storage requirement to the formulary.

1

Right organism, right protocol

Give staff clear directions for routine disinfection and label-listed high-priority pathogen protocols.

2

One-product standardization

Reduce unnecessary variation in products, inventory, contact times, and training while keeping claim-specific directions clear.

3

Stronger staff adoption

Make onboarding and day-to-day execution easier across shifts and departments.

4

Measurable implementation

Use concentration checks, training records, supervisor review, purchasing, inventory, packaging, and site data to show whether the standard is working.

C. difficile: Keep the Hard Cases Inside the Same Standard

Facilities should not need another disinfectant decision every time a high-risk organism appears. EraDOCator-60 includes a defined 4-minute protocol for C. difficile.

EPA List K verification

EraDOCator-60's primary registration can be independently cross-checked on EPA List K.

Label-defined 4-minute protocol

The current label specifies the preparation directions required for the C. difficile claim. Buyers can verify those details directly on the label.

Four-minute wet contact time

Staff have a clear organism-specific target rather than an open-ended workflow.

Operational verification

Training, concentration verification, supervisor review, and room-level process measures can support implementation.

That keeps C. difficile inside the EraDOCate operating platform rather than turning an outbreak into another product-selection decision.

Before You Renew the Current Program, Look at the Whole Cost

The price on the invoice is only one part of the disinfection program. These questions help Procurement, EVS, Infection Prevention, Operations, Sustainability, and Finance identify where consolidation may create operating or stewardship value.

  • How many disinfectant products and SKUs does the facility purchase today, and which organisms or workflows require each one?
  • How many different contact times, application methods, product identities, and exception protocols must staff remember?
  • How many ready-to-use bottles, wipe canisters, cases, and pallets are purchased, received, and moved through the facility each month or year?
  • How much EVS, housekeeping, janitorial-closet, central-supply, or storeroom space is dedicated to disinfectant inventory?
  • How often are disinfectants moved from receiving to central storage and then redistributed to departments, floors, closets, carts, or satellite locations?
  • How many plastic bottles, triggers, wipe canisters, caps, cartons, and other packages enter recycling or waste streams because of the current disinfectant program?
  • What does the organization spend on receiving, stocking, inventory management, recycling, waste hauling, and internal handling related to those products and containers?
  • How much product expires, remains partially used, is discarded after a protocol change, or sits in duplicate inventory across departments?
  • Does an outbreak or high-priority organism require staff to change disinfectants, retrieve another product, retrain the workflow, or maintain separate emergency inventory?
  • What is the true lifecycle cost after product, freight, storage, labor, training, dispensing, packaging, recycling or disposal, product switching, verification, and implementation are considered?

Make the Switch Practical

EraDOCate can help your team compare the current program, identify what one platform may replace, conduct a focused implementation review, measure the clinical and operating workflow, and decide whether broader standardization makes sense.

1. Review the current program

Document products, SKUs, contact times, purchasing, storage, packaging, dilution, staff training, waste handling, outbreak-specific products, and workflow pain points.

2. Build the EraDOCate implementation plan

Choose a defined area and establish the product, dilution, OCEAN training, and verification workflow.

3. Measure what matters

Review staff adoption, concentration checks, turnover workflow, product count, storage, packaging, purchasing, surface feedback, cost, and ATP where appropriate.

4. Decide whether to standardize

Use the implementation data to support Infection Prevention, Procurement, Operations, Administration, Sustainability, and Finance review.

Evidence & Resources

For teams that want to go deeper, these references support review of C. auris, C. difficile, QAC exposure, residue, wastewater, environmental stewardship, and operational decision-making.

Evidence and website content reviewed August 2026. Research informs due diligence; it does not expand the EPA product label.
For due diligence

See the evidence behind the conversation

Use these resources when Infection Prevention, Procurement, Safety, Sustainability, or Administration wants to review the science and guidance in more detail.

Infection prevention CDC and EPA guidance for C. auris, C. difficile, contact time, and environmental cleaning.
Worker health Research on repeated disinfectant exposure, inhalation, respiratory outcomes, and occupational use.
Environmental stewardship Research on wastewater, textiles, water, environmental pathways, One Health, and antimicrobial resistance.
Product review EraDOCate regulatory documents, label-based protocols, training, and implementation support.
C. auris and C. diff
Contact time
QAC inhalation and exposure pathways
Residue and environmental release
Wastewater and biosolids
Plants, animals, and water
Storage & inventory
Policy and procurement
CDCCDC C. auris Infection Control
CDC states that accumulating data indicate products solely dependent on QACs are not effective against C. auris and recommends an EPA-registered hospital-grade disinfectant effective against C. auris. Open reference
CDCCDC C. auris Surface Disinfection
CDC recommends EPA-registered products specifically for C. auris contamination. Open reference
CNNCNN QAC Disinfectant Coverage
Mainstream public-health coverage of QAC exposure concerns and the growing discussion around repeated disinfectant use. Open reference
EPAEPA List P
EPA products with registered claims against Candida auris. Open reference
EPAEPA List K
EPA products with registered claims against C. diff spores. Open reference
CDICDC C. diff Prevention Guidance
CDC calls for daily cleaning of CDI patient rooms with a C. difficile sporicidal agent from EPA List K. Open reference
IPCDC STRIVE Environmental Cleaning
Training material highlights label directions, dilution, contact time, surface compatibility, and safe use instructions. Open reference
SHEASHEA C. diff Prevention Update
Practical recommendations for acute-care hospitals to prioritize CDI prevention efforts. Open reference
CDISporicidal Cleaning Model
Daily cleaning with sporicidal disinfectant ranked among the most effective single interventions for reducing HO-CDI. Open reference
EPAEPA Residue Test Methods
EPA finalized methods for measuring QAC and phenolic disinfectant residues on hard surfaces. Open reference
AIRUC Davis QAC Inhalation Study
Mouse-model study comparing inhaled and oral QAC exposure. Useful for route-of-exposure questions; not direct clinical evidence of harm in humans. Open reference
QACQAC Chemical Class Review
Peer-reviewed review of QAC use, exposure, environmental fate, health-effect literature, and antimicrobial-resistance concerns; useful as a synthesis rather than product-specific proof. Open reference
WWTPQACs in Wastewater and Biosolids
Environmental Science and Technology study analyzing 21 QACs in wastewater influent, effluent, and biosolids from 12 treatment plants. Open reference
TXTQACs in Textiles and Laundry Wastewater
Study relevant to healthcare linens, hotel towels, uniforms, long-term care laundry, and treated textile stewardship. Open reference
PLANTQAC Uptake in Wheat Seedlings
2026 research on uptake and metabolism of DTAC, DBAC, and DDAC in hydroponically grown wheat seedlings. Open reference
H2OQACs in Water, Stormwater, and Rainwater
Survey of 27 QACs in New York surface water, drinking water, stormwater runoff, swimming pool water, and rainwater. Open reference
FISHBenzalkonium Chloride and Fish Resistance Genes
Journal of Hazardous Materials study connecting environmental BAC exposure with resistance-gene profiles in fish. Open reference
ALGAEDDAC and Microalgae Stress
Study on DDAC effects on microalgal cell-surface properties, molecular toxicity, and pollutant-removal function. Open reference
NPICQAC Proper-Use Context
National Pesticide Information Center fact sheet for balanced QAC background and proper-use framing. Open reference
CVDNurses’ Health Study II: Disinfectants and CVD
Prospective observational study of nurses reporting an association between frequent occupational disinfectant exposure and incident cardiovascular disease. It does not by itself show that QAC exposure alone caused the association. Open reference
RSDisinfectants and Asthma Risk
Occupational study evaluating associations between disinfectant/cleaning-product exposure patterns and asthma. Interpret by exposure definition and study design. Open reference
MITOQACs and Mitochondrial Stress
Cell-model research evaluating QAC-related mitochondrial effects. Mechanistic evidence, not direct clinical-outcome evidence. Open reference
QACQACs in Assisted Living
2026 study assessing 19 QACs across assisted living facilities. Open reference
QACQAC Surface Residue Exposure
Exposure-pathway study evaluating QACs across environmental and human-contact measures. Useful for exposure characterization, not proof of a specific clinical outcome. Open reference
HAIHospital Room Cleaning Review
Technical brief on cleaning hospital room surfaces to prevent HAIs. Open reference
ICUCarling ICU Hygiene Study
Structured intervention improved environmental hygiene in ICUs. Open reference
EDEraDOCate Insights
Articles, podcasts, QAC discussion, WPI summary, and policy commentary. Open reference
VIDEraDOCate Videos
Video content for education, sales support, and implementation conversations. Open reference

Ready to See What One EraDOCate Platform Could Replace?

We can review your current products, SKUs, contact times, purchasing, storage, packaging, internal distribution, workflow, training, worker-safety considerations, stewardship priorities, and waste-handling model, then show you what a more standardized EraDOCate program could look like.

www.eradocateusa.com | 1 (866) ERADOCATE
EraDOCator-60 EPA Reg. No. 54289-4-102813. Always read and follow the current label and SDS. EPA registration does not imply EPA endorsement.

Start With a Structured Comparison

  • Current products, SKUs, and contact times
  • High-priority organisms
  • Purchasing, storage, dilution, and dispensing
  • Training, workflow, and product switching
  • PPE, application method, ventilation, and worker-safety considerations
  • Surface, rinse, and compatibility requirements
  • Packaging, waste, and implementation opportunity
  • Lifecycle cost, value-analysis, and implementation questions
i

Product Use and Results Disclaimer

EraDOCate products are EPA-registered disinfectants. EPA registration does not imply EPA endorsement and does not replace the requirement to read and follow the product label, SDS, facility protocols, and applicable infection-prevention policies. Contact times, organisms, use sites, dilution, application methods, PPE, storage, disposal, and safety requirements vary by product and label. Testimonials, pilot results, field examples, and case references reflect specific settings and may not represent expected results in every facility. EraDOCate does not replace clinical judgment, regulatory guidance, or facility infection-control oversight.